Summary & Overview
HCPCS Q4184: Cellesta Duo per Square Centimeter, Add-On
HCPCS Level II code Q4184 denotes Cellesta or Cellesta Duo billed per square centimeter as an add-on, list-separately product used in aesthetic and dermatologic procedures. Nationally, this code matters for providers and payers because it clarifies billing for area-based adjunct products that supplement a primary procedural service, affecting claims categorization and unit-based pricing.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code's clinical context and service settings, an explanation of billing considerations for add-on, per-square-centimeter products, and what metrics and benchmarks are typically tracked for such HCPCS Level II product codes.
The publication outlines expected use cases in outpatient clinics, ambulatory surgical centers, and physician offices; common billing modifiers and payer considerations; and where to look for policy guidance and coverage criteria. Data not provided in the input (such as associated taxonomies, specific ICD-10 diagnoses, and payer-specific coverage rules) is noted as unavailable. The piece aims to inform coding teams, billing managers, and policy analysts about the operational implications of using Q4184 alongside primary procedural billing.
Billing Code Overview
HCPCS Level II code Q4184 represents Cellesta or Cellesta Duo billed per square centimeter as an add-on service to be listed separately in addition to a primary procedure. The code denotes a product-based dermal or aesthetic adjunct applied in a measured surface area and is invoiced in units corresponding to square centimeters.
Service Type: Aesthetic/dermal product application (add-on)
Typical Site of Service: Outpatient clinic, ambulatory surgical center, or physician office where aesthetic or dermatologic procedures are performed.
Clinical & Coding Specifications
Clinical Context
A middle-aged patient with a localized dermatologic defect undergoes a skin resurfacing or wound-repair procedure in a dermatology or plastic surgery setting. The clinician elects to apply a topical biologic implant product, billed as Q4184 (Cellesta or Cellesta Duo, per square centimeter) as an add-on to the primary procedure. Typical sites of service include an ambulatory surgery center, hospital outpatient department, or office-based procedure room under sterile conditions. The workflow: the patient is evaluated pre-procedure for wound dimensions and suitability for topical biologic application; the primary procedure (for example, excision, debridement, or skin grafting) is performed; the provider measures the square centimeters of product required; Q4184 is billed as an add-on line item in addition to the primary CPT procedure; documentation includes wound size, product lot/strength, application technique, and postoperative care instructions. Common clinical indications include non-healing surgical wounds, chronic ulcers managed with adjunctive biologic matrix placement, or augmentation of reconstructive procedures to promote soft-tissue healing.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — standard reporting | Used when no special circumstances apply and the service is billed in the usual manner. |